Cargando…
LATITUDE: A landmark trial for high-risk metastatic castration-sensitive prostate cancer: Final overall survival analysis
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6961436/ https://www.ncbi.nlm.nih.gov/pubmed/31983834 http://dx.doi.org/10.4103/iju.IJU_258_19 |
_version_ | 1783487993233801216 |
---|---|
author | Kumar, Gautam |
author_facet | Kumar, Gautam |
author_sort | Kumar, Gautam |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-6961436 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-69614362020-01-24 LATITUDE: A landmark trial for high-risk metastatic castration-sensitive prostate cancer: Final overall survival analysis Kumar, Gautam Indian J Urol Uroscan Wolters Kluwer - Medknow 2020 /pmc/articles/PMC6961436/ /pubmed/31983834 http://dx.doi.org/10.4103/iju.IJU_258_19 Text en Copyright: © 2020 Indian Journal of Urology http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Uroscan Kumar, Gautam LATITUDE: A landmark trial for high-risk metastatic castration-sensitive prostate cancer: Final overall survival analysis |
title | LATITUDE: A landmark trial for high-risk metastatic castration-sensitive prostate cancer: Final overall survival analysis |
title_full | LATITUDE: A landmark trial for high-risk metastatic castration-sensitive prostate cancer: Final overall survival analysis |
title_fullStr | LATITUDE: A landmark trial for high-risk metastatic castration-sensitive prostate cancer: Final overall survival analysis |
title_full_unstemmed | LATITUDE: A landmark trial for high-risk metastatic castration-sensitive prostate cancer: Final overall survival analysis |
title_short | LATITUDE: A landmark trial for high-risk metastatic castration-sensitive prostate cancer: Final overall survival analysis |
title_sort | latitude: a landmark trial for high-risk metastatic castration-sensitive prostate cancer: final overall survival analysis |
topic | Uroscan |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6961436/ https://www.ncbi.nlm.nih.gov/pubmed/31983834 http://dx.doi.org/10.4103/iju.IJU_258_19 |
work_keys_str_mv | AT kumargautam latitudealandmarktrialforhighriskmetastaticcastrationsensitiveprostatecancerfinaloverallsurvivalanalysis |